title: Gunvalson decision sends shockwaves through industry.
authors.forename: Malorye
authors.initials: M
authors.lastname: Allison
mesh_terms: D000293:Adolescent; D000328:Adult; D001709:Biotechnology / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D035082:Federal Government; D005260:Female; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006801:Humans; D007603:Jurisprudence; D008297:Male; D009136:Muscular Dystrophies / Q000188:drug therapy*; D009515:New Jersey; D010069:Oxadiazoles / Q000627:therapeutic use*; D028701:Patient Rights / Q000331:legislation & jurisprudence
chemical_list: D015507:Drugs, Investigational; D010069:Oxadiazoles; C515878:ataluren